Table 3.
Characteristics | Early infection (≤6 months) (N = 49) | Late infection (>6 months) (N = 170) | p | OR (95%CI) |
---|---|---|---|---|
Underlying diseases | ||||
Lung diseases, n (%) | 10 (20.4) | 14 (8.2) | 0.016 | 2.857 (1.180-6.917) |
Renal diseases, n (%) | 5 (10.2) | 18 (10.6) | 0.938 | |
Liver diseases, n (%) | 4 (8.2) | 23 (13.5) | 0.314 | |
Diabetes mellitus, n (%) | 17 (34.7) | 36 (21.2) | 0.052 | |
Hypertension, n (%) | 25 (51.0) | 81 (47.6) | 0.677 | |
Positive test results | ||||
TEE∗, n (%) | 4 (8.2) | 7 (4.1) | 0.253 | |
Blood culture, n (%) | 8 (16.3) | 16 (9.4) | 0.107 | |
Pocket tissue culture, n (%) | 35 (71.4) | 110 (64.7) | 0.381 | |
Outcomes | ||||
Median length of stay (max, min), days | 15 (12-19) | 15 (13-20) | 0.694 | |
In-hospital death, n (%) | 1 (2.0) | 1 (0.6) | 0.346 | |
∗TEE, transesophageal echocardiography.